WallStreetZenWallStreetZen

NASDAQ: STIM
Neuronetics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for STIM

Based on 2 analysts offering 12 month price targets for Neuronetics Inc.
Min Forecast
$7.00+149.11%
Avg Forecast
$9.50+238.08%
Max Forecast
$12.00+327.05%

Should I buy or sell STIM stock?

Based on 2 analysts offering ratings for Neuronetics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their STIM stock forecasts and price targets.

STIM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Canaccord Genuity
Bottom 11%
11
Strong BuyMaintains$7.00+149.11%2023-03-08
JMP Securities
Bottom 14%
14
BuyReiterates$12.00+327.05%2023-03-08

1 of 1

Forecast return on equity

Is STIM forecast to generate an efficient return?
Company
-42.75%
Industry
197.86%
Market
51.53%
STIM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STIM forecast to generate an efficient return on assets?
Company
-20.87%
Industry
11.32%
STIM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STIM earnings per share forecast

What is STIM's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.49
Avg 2 year Forecast
-$0.86

STIM revenue forecast

What is STIM's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$70.9M+8.75%
Avg 2 year Forecast
$84.1M+28.91%
STIM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STIM revenue growth forecast

How is STIM forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
8.75%
Industry
5.66%
Market
25.31%
STIM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STIM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STIM vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
STIM$2.81$9.50+238.08%Strong Buy
RNLX$2.07$6.67+222.08%Strong Buy
GTH$0.96$10.00+941.67%Strong Buy
AKU$0.78$3.00+284.62%Buy
MYNZ$6.33$17.00+168.56%Strong Buy
View Top Diagnostic & Research Stocks

Neuronetics Stock Forecast FAQ

Is Neuronetics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: STIM) stock is to Strong Buy STIM stock.

Out of 2 analysts, 1 (50%) are recommending STIM as a Strong Buy, 1 (50%) are recommending STIM as a Buy, 0 (0%) are recommending STIM as a Hold, 0 (0%) are recommending STIM as a Sell, and 0 (0%) are recommending STIM as a Strong Sell.

If you're new to stock investing, here's how to buy Neuronetics stock.

What is STIM's earnings growth forecast for 2023-2024?

(NASDAQ: STIM) Neuronetics's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 34.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 77.85%.

Neuronetics's earnings in 2023 is -$37,159,000.On average, 2 Wall Street analysts forecast STIM's earnings for 2023 to be -$42,261,496, with the lowest STIM earnings forecast at -$46,799,643, and the highest STIM earnings forecast at -$37,439,714.

In 2024, STIM is forecast to generate -$24,392,541 in earnings, with the lowest earnings forecast at -$24,392,541 and the highest earnings forecast at -$24,392,541.

What is STIM's revenue growth forecast for 2023-2024?

(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 8.75% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.

Neuronetics's revenue in 2023 is $65,206,000.On average, 2 Wall Street analysts forecast STIM's revenue for 2023 to be $2,011,250,112, with the lowest STIM revenue forecast at $1,968,421,348, and the highest STIM revenue forecast at $2,054,078,876.

In 2024, STIM is forecast to generate $2,384,229,085 in revenue, with the lowest revenue forecast at $2,384,229,085 and the highest revenue forecast at $2,384,229,085.

What is STIM's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: STIM) forecast ROA is -20.87%, which is lower than the forecast US Diagnostics & Research industry average of 11.32%.

What is STIM's Price Target?

According to 2 Wall Street analysts that have issued a 1 year STIM price target, the average STIM price target is $9.50, with the highest STIM stock price forecast at $12.00 and the lowest STIM stock price forecast at $7.00.

On average, Wall Street analysts predict that Neuronetics's share price could reach $9.50 by Mar 8, 2024. The average Neuronetics stock price prediction forecasts a potential upside of 238.08% from the current STIM share price of $2.81.

What is STIM's Earnings Per Share (EPS) forecast for 2023-2024?

(NASDAQ: STIM) Neuronetics's current Earnings Per Share (EPS) is -$1.38. On average, analysts forecast that STIM's EPS will be -$1.49 for 2023, with the lowest EPS forecast at -$1.65, and the highest EPS forecast at -$1.32. In 2024, STIM's EPS is forecast to hit -$0.86 (min: -$0.86, max: -$0.86).

What is STIM's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: STIM) forecast ROE is -42.75%, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.